Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin. uri icon

authors

  • List, Alan F
  • Claxton, David F
  • Luger, Selina M
  • Mattison, Ryan J
  • Wassenaar, Timothy R
  • Andrew Artz, MD, MS
  • Schiffer, Charles A
  • Litzow, Mark R
  • Tallman, Martin S
  • Sun, Zhuoxin
  • Verma, Amit
  • Bennett, John M
  • Komrokji, Rami S
  • McGraw, Kathy
  • Maciejewski, Jaroslaw
  • Altman, Jessica K
  • Cheema, Puneet S

publication date

  • January 1, 2021